By Business/Source
Currency:USD
2023/FY
Stock NameRevenueRatio
Research and development of novel therapeutics for patients, including the advancement of PALI-2108250K100.00%
By Country/Region
Currency:USD
2023/FY
Stock NameRevenueRatio
U.S.250K100.00%